BRAIN and NERVE Shinkei Kenkyu no Shinpo Volume 71, Issue 5 (May 2019)
Japanese

Neuropsychiatric Systemic Lupus Erythematosus Yoshiya Tanaka 1 1The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Keyword: 全身性エリテマトーデス , 中枢神経系 , 神経精神ループス , 治療 , 生物学的製剤 , systemic lupus erythematosus , central nervous system , neuropsychiatric lupus , treatment pp.445-458
Published Date 2019/5/1
DOI https://doi.org/10.11477/mf.1416201297
  • Abstract
  • Look Inside
  • Reference

Abstract

Systemic lupus erythematosus (SLE) is a representative autoimmune disease that is characterized by a variety of manifestations affecting multiple organs. Damage to the central nervous system is one example of how SLE can manifest and cause significant morbidity and mortality. The American College of Rheumatology defines neuropsychiatric SLE (NPSLE) as involving the central and peripheral nervous systems, which can include overt symptoms such as stroke, seizures, and psychosis. Recommendations from the international task force regarding the treat-to-target approach in SLE include targeting remission, preventing further damage, and improving quality of life. When a patient exhibits high disease activity and organ damage, treatment is initiated with a high dose of glucocorticoid and immunosuppressants. Recent innovative approaches to treatment include using biologics and JAK inhibitors, with high expectations of improving SLE management.


Copyright © 2019, Igaku-Shoin Ltd. All rights reserved.

基本情報

18816096.71.5.jpg
BRAIN and NERVE-神経研究の進歩
71巻5号 (2019年5月)
電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有